HLA型檢測市場規模、佔有率和成長分析：按產品/服務、技術、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球HLA型檢測市場價值為 14 億美元，預計到 2025 年將成長至 14.9 億美元，到 2033 年將成長至 24.9 億美元，在預測期（2026-2033 年）內複合年成長率為 6.6%。

全球HLA型檢測市場的主要驅動力是日益成長的組織相容性精準度需求，這對於器官和幹細胞移植的成功至關重要。隨著臨床醫師努力降低移植排斥反應，定序試劑和耗材市場也不斷擴大。從血清學到次世代定序，調查方法的演進使得高解析度分型和更快的結果交付成為可能。次世代定序與生物資訊學的融合提高了匹配準確性，減少了移植後併發症，從而降低了醫療成本。這反過來又促使保險公司和醫療系統加大對分型檢查室的投資，促進了規模經濟。此外，免疫腫瘤學和個人化醫療的發展也推動了對精準HLA分型的需求成長，透過診斷公司和治療研發公司之間的合作，在癌症治療領域創造了新的收入來源和應用領域。人工智慧進一步提升了該市場的準確性和效率。

全球HLA型檢測市場促進因素

全球HLA型檢測市場的發展動力源自於器官移植中對精準捐贈者配型日益成長的需求，因為精確的抗原組合能夠降低排斥風險並指南免疫抑制治療。這種需求的成長促使檢查室和移植中心將全面的HLA檢測列為優先事項，最終提高了移植成功率和患者照護。因此，對先進平台和檢測服務的投資激增，促進了臨床團隊和診斷機構之間的合作。隨著臨床決策越來越依賴詳細的HLA數據，標準化、高解析度分型方法的應用也不斷推進，加速了HLA檢測融入常規移植流程。

全球HLA型檢測市場的限制因素

先進的HLA型檢測技術需要高昂的資本投入和營運成本，包括設備購買、維護和耗材費用，對小規模檢查室和醫療機構來說是一個障礙。這些財務挑戰會阻礙高解析度技術的應用，並延緩向更先進系統的過渡。此外，有限的報銷選擇和嚴格的預算限制也阻礙了技術的廣泛應用，導致醫療機構優先選擇成熟且經濟高效的方法，而非創新的替代方案。因此，儘管臨床上需要提高檢測能力，但這些經濟限制導致能夠提供全面HLA型檢測服務的機構數量有限，阻礙了市場成長。

全球HLA型檢測市場趨勢

全球HLA型檢測市場正經歷著向精準醫療的顯著轉變，對高解析度HLA型檢測的需求迅速成長，旨在提升個人化療法和免疫療法的療效。這一趨勢促進了診斷檢查室、學術研究機構和治療方法研發者之間更緊密的合作，凸顯了等位基因水平的準確性和標準化報告的重要性。隨著支付方和醫療服務提供者將臨床效用置於優先地位，能夠與基因組數據和臨床決策支援系統無縫整合的綜合性HLA工作流程正日益普及。這最終將有助於建立個別化診療路徑，並最佳化移植和免疫治療領域的患者預後。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 價值鏈分析
• 案例研究
• 技術評估
• 客戶和採購標準分析
• 管道分析
• 疾病流行病學

全球HLA型檢測市場規模：依產品/服務分類

• 試劑和耗材
• 裝置
• 軟體服務

全球HLA型檢測市場規模：依技術分類

• 分子檢測
  • 基於PCR的
  • 次世代定序（NGS）
  • 基於微陣列
• 非分子方法

全球HLA型檢測市場規模：依應用領域分類

• 移植診斷
  • 固態器官移植
  • 幹細胞移植
• 疾病診斷
• 出於研究目的

全球HLA型檢測市場規模：依最終用戶分類

• 醫院及移植中心
• 診斷檢查室
• 研究和學術機構
• 商業服務供應商

全球HLA型檢測市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific
• F. Hoffmann-La Roche Ltd
• Becton, Dickinson and Company（BD）
• Illumina, Inc.
• QIAGEN NV
• Bio-Rad Laboratories
• CareDx, Inc.
• Immucor, Inc.
• Omixon Inc.
• GenDx
• Takara Bio Inc.
• Bio-Techne Corporation
• Luminex Corporation（DiaSorin）
• Abbott Molecular
• Pacific Biosciences
• Eurofins Scientific
• Labcorp
• BAG Healthcare GmbH
• TBG Diagnostics Ltd.
• HistoGenetics

結論與建議

Global Hla Typing Market size was valued at USD 1.4 Billion in 2024 and is poised to grow from USD 1.49 Billion in 2025 to USD 2.49 Billion by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).

The global HLA typing market is primarily driven by the increasing demand for accurate tissue matching, crucial for successful organ and stem cell transplantation. As clinicians aim to minimize graft rejection, markets for sequencing reagents and consumables are expanding. Evolving methodologies, from serology to next-generation sequencing, enable high-resolution typing with faster turnaround times. The integration of next-generation sequencing and bioinformatics enhances match accuracy and reduces post-transplant complications, consequently lowering healthcare costs. This leads to increased investments in typing labs by payers and health systems, fostering economies of scale. Additionally, the growth of immuno-oncology and personalized therapies generates demand for precise HLA profiling, with diagnostic companies collaborating with therapy developers, creating new revenue streams and applications in cancer treatments. AI further enhances accuracy and efficiency within this market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hla Typing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hla Typing Market Segments Analysis

Global hla typing market is segmented by product & services, technology, application, end-user and region. Based on product & services, the market is segmented into Reagents & Consumables, Instruments and Software & Services. Based on technology, the market is segmented into Molecular Assays and Non-Molecular Assays. Based on application, the market is segmented into Transplant Diagnostics, Disease Diagnosis and Research Applications. Based on end-user, the market is segmented into Hospitals & Transplant Centers, Diagnostic Laboratories, Research & Academic Institutes and Commercial Service Providers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hla Typing Market

The global HLA typing market is significantly influenced by the increasing necessity for accurate donor-recipient matching in organ transplantation, as precise antigen matching diminishes rejection risks and informs immunosuppressive approaches. This heightened demand prompts laboratories and transplant centers to emphasize thorough HLA testing, which ultimately enhances graft success and patient care. Consequently, there is a surge in investments towards cutting-edge platforms and expanded testing offerings, fostering collaborations between clinical teams and diagnostic providers. As clinical decision-making increasingly relies on detailed HLA data, the adoption of standardized and high-resolution typing methods accelerates the integration of HLA testing into everyday transplant procedures.

Restraints in the Global Hla Typing Market

The high capital and operational expenses linked to sophisticated HLA typing technologies, which encompass instrument purchase, upkeep, and consumables, create barriers for smaller laboratories and healthcare facilities. These financial challenges hinder the adoption of high-resolution technologies and may postpone the transition to more advanced systems. Additionally, limited reimbursement options and stringent budgetary restrictions deter broader implementation, leading facilities to favor established, cost-effective methods over more innovative alternatives. As a result, these economic constraints impede market growth by restricting the number of locations equipped to provide comprehensive HLA typing services, despite a clinical need for enhanced testing capabilities.

Market Trends of the Global Hla Typing Market

The Global HLA Typing market is witnessing a significant shift towards precision medicine, where the demand for high-resolution HLA typing is rapidly increasing to enhance the efficacy of personalized therapies and immune-based treatments. This trend is fostering closer synergies between diagnostic laboratories, academic research institutions, and therapeutic developers, emphasizing the need for allele-level accuracy and standardized reporting. As payers and healthcare providers prioritize clinical utility, there is growing momentum for the adoption of comprehensive HLA workflows that integrate seamlessly with genomic data and clinical decision-support systems, ultimately facilitating individualized care pathways and optimizing patient outcomes in transplant and immunotherapy settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Value Chain Analysis
• Case Studies
• Technology Assessment
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology

Global HLA Typing Market Size by Product & Services & CAGR (2026-2033)

• Market Overview
• Reagents & Consumables
• Instruments
• Software & Services

Global HLA Typing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Molecular Assays
  • PCR-Based
  • Next-Generation Sequencing (NGS)
  • Microarray-Based
• Non-Molecular Assays

Global HLA Typing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Transplant Diagnostics
  • Solid Organ Transplantation
  • Stem Cell Transplantation
• Disease Diagnosis
• Research Applications

Global HLA Typing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Transplant Centers
• Diagnostic Laboratories
• Research & Academic Institutes
• Commercial Service Providers

Global HLA Typing Market Size & CAGR (2026-2033)

• North America (Product & Services, Technology, Application, End-User)
  • US
  • Canada
• Europe (Product & Services, Technology, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Technology, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Technology, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Technology, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Immucor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omixon Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenDx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Techne Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (DiaSorin)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Molecular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BAG Healthcare GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TBG Diagnostics Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HistoGenetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations